CRISM Therapeutics Corporation (CRTX) — Cash Flow-to-Debt Ratio
CRISM Therapeutics Corporation (CRTX) has a Cash Flow-to-Debt Ratio of -2.88x as of December 2025, meaning its operating cash flow of GBX-1.10 Million could theoretically repay -3% of its total liabilities (GBX381.00K) in one year. See CRISM Therapeutics Corporation (CRTX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CRISM Therapeutics Corporation Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for CRISM Therapeutics Corporation across 20 annual periods. For the full cash flow conversion analysis, see CRISM Therapeutics Corporation cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for CRISM Therapeutics Corporation (2006–2025)
Year-by-year debt coverage analysis for CRISM Therapeutics Corporation. Check earnings quality score of CRISM Therapeutics Corporation to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.16x | GBX-1.97 Million | GBX381.00K | ▼ -88.7% |
| 2024 | -2.74x | GBX-933.00K | GBX341.00K | ▲ +9.1% |
| 2023 | -3.01x | GBX-2.77 Million | GBX920.19K | ▲ +34.4% |
| 2022 | -4.59x | GBX-3.52 Million | GBX765.65K | ▼ -182.3% |
| 2021 | -1.63x | GBX-1.83 Million | GBX1.13 Million | ▲ +24.9% |
| 2020 | -2.17x | GBX-2.28 Million | GBX1.05 Million | ▲ +2.9% |
| 2019 | -2.23x | GBX-1.90 Million | GBX852.24K | ▼ -151.2% |
| 2018 | -0.89x | GBX-2.46 Million | GBX2.76 Million | ▲ +69.0% |
| 2017 | -2.86x | GBX-2.70 Million | GBX944.00K | ▼ -453.2% |
| 2016 | -0.52x | GBX-2.01 Million | GBX3.88 Million | ▲ +87.7% |
| 2015 | -4.22x | GBX-2.99 Million | GBX709.20K | ▲ +12.4% |
| 2014 | -4.81x | GBX-1.96 Million | GBX407.00K | ▲ +77.9% |
| 2013 | -21.79x | GBX-1.62 Million | GBX74.25K | ▼ -112.4% |
| 2012 | -10.26x | GBX-750.98K | GBX73.21K | ▲ +60.8% |
| 2011 | -26.17x | GBX-2.67 Million | GBX102.00K | ▼ -268.6% |
| 2010 | -7.10x | GBX-778.08K | GBX109.60K | ▼ -143.5% |
| 2009 | -2.92x | GBX-843.95K | GBX289.43K | ▲ +58.7% |
| 2008 | -7.06x | GBX-2.06 Million | GBX292.12K | ▼ -78.6% |
| 2007 | -3.95x | GBX-692.47K | GBX175.32K | ▲ +93.8% |
| 2006 | -63.55x | GBX-998.08K | GBX15.71K | — |